Black P, Carroll R, Zhang J
Neurosurgery Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Acta Neurochir Suppl. 1996;65:50-3. doi: 10.1007/978-3-7091-9450-8_15.
Expression of a number of steroid hormone and growth factor receptors is characteristic of meningiomas. This paper reviews the analysis of receptors for progesterone, estrogen, androgen and platelet derived growth factor (PDGF) in human meningioma tissue specimens. Progesterone receptor was assessed by Northern blot analysis and immunohistochemistry in meningioma tissue specimens. Progesterone receptor mRNA was expressed in 64% of the meningiomas examined. Immunohistochemical data correlated well with the Northern blot analysis. The staining was clearly nuclear. Expression was more common in meningioma tissue from women than from men. Analysis of receptor expression in tissue culture derived from meningioma specimens demonstrated the loss of progesterone receptor within one to two passages. It was shown that the progesterone receptor mRNA expression which is present in meningiomas is functional by transfection techniques. The estrogen receptor was undetectable by Northern blot analysis; a small amount could be detected in meningioma tissue specimens by polymerase chain reaction (PCR). The androgen receptor was found in 67% of the specimens examined. Like the progesterone receptor, it was more common in women than in men (69% vs. 31%). The immunohistochemical data correlated well with the Northern blot analysis, with the receptor predominantly found in the nucleus. Unlike progesterone receptor, androgen receptor expression was not lost in cell culture. The subunits for PDGF were expressed in various quantities in meningiomas. Only the PDGF beta-receptor (PDGFR-beta) not alpha-receptor, was found in meningioma tissue specimens. In contrast, the ligands PDGF A and PDGF B were expressed in all tumors. The functionality of the PDGF beta-R was determined by examining the induction of the protooncogene C-fos by PDGF BB in meningioma cell cultures. A significant increase in C-fos protein was observed with the addition of PDGF BB to meningioma cultures.
多种类固醇激素和生长因子受体的表达是脑膜瘤的特征。本文综述了人脑膜瘤组织标本中孕激素、雌激素、雄激素和血小板衍生生长因子(PDGF)受体的分析情况。通过Northern印迹分析和免疫组织化学对脑膜瘤组织标本中的孕激素受体进行评估。在所检测的脑膜瘤中,64%表达孕激素受体mRNA。免疫组织化学数据与Northern印迹分析结果高度相关。染色明显位于细胞核。女性脑膜瘤组织中的表达比男性更常见。对源自脑膜瘤标本的组织培养物中的受体表达分析表明,在传代一至两次后孕激素受体丢失。通过转染技术表明,脑膜瘤中存在的孕激素受体mRNA表达具有功能。通过Northern印迹分析未检测到雌激素受体;通过聚合酶链反应(PCR)在脑膜瘤组织标本中可检测到少量雌激素受体。在所检测的67%的标本中发现了雄激素受体。与孕激素受体一样,女性中的表达比男性更常见(69%对31%)。免疫组织化学数据与Northern印迹分析结果高度相关,受体主要位于细胞核中。与孕激素受体不同,雄激素受体表达在细胞培养中未丢失。PDGF的亚基在脑膜瘤中以不同数量表达。在脑膜瘤组织标本中仅发现了PDGFβ受体(PDGFR-β),而未发现α受体。相反,配体PDGF A和PDGF B在所有肿瘤中均有表达。通过检测PDGF BB在脑膜瘤细胞培养物中对原癌基因C-fos的诱导来确定PDGFβ-R的功能。在脑膜瘤培养物中添加PDGF BB后,观察到C-fos蛋白显著增加。